Full Press Release Details
Cadre Holdings Reports Third Quarter 2025 Financial Results
Grew Quarterly Net Sales 42% and Gross Profit 66% Year-Over-Year
Increased Quarterly Adjusted EBITDA of $29.8 Million and Expanded Adjusted EBITDA Margin of 19.1%
Organic Backlog Increased $20 Million from Q2 to Q3
Med-Eng Awarded $50 Million IDIQ with DoD - First PO issued for $10 Million to be Shipped in 2026
Agrees to Acquire TYR Tactical, Leading Provider of Plate Carriers, Vests, Hard Armor, and Shields
JACKSONVILLE, Fla., November 4, 2025 - Cadre Holdings, Inc. (NYSE: CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three and nine months ended September 30, 2025.
"We are pleased to report another quarter of strong performance, driven by Cadre's industry leading brands and favorable trends across our law enforcement, first responder, military, and nuclear end-markets," said Warren Kanders, CEO and Chairman. "Our teams delivered results above expectations, while expanding our backlog significantly and advancing Cadre's track record of consistent and stable growth despite a dynamic operating environment. Revenue, gross profit, net income, and Adjusted EBITDA increased significantly this quarter, with an Adjusted EBITDA margin that improved 670 basis points year-over-year."
Mr. Kanders added, "Our recently announced agreement to acquire TYR Tactical marks Cadre's sixth and largest acquisition since going public and a meaningful step forward in strengthening our diversified platform of durable safety businesses. Cadre's disciplined M&A program is crucial to accelerating long-term growth, and we are excited to have once again delivered on our pledge to capitalize on attractive inorganic opportunities. Building on our current momentum, we remain focused on pursuing additional transactions in line with our highly selective key criteria and continuing to take advantage of the free cash flow generated by the strong and recurring demand for our mission-critical safety and survivability equipment."
Third Quarter and Nine-Month 2025 Operating Results
For the quarter ended September 30, 2025, Cadre generated net sales of $155.9 million, as compared to $109.4 million for the quarter ended September 30, 2024. This increase was primarily a result of recent acquisitions and strong demand for armor and duty gear products, as well as the impact of the 2024 cyber incident on the comparable period.
For the nine months ended September 30, 2025, Cadre generated net sales of $443.1 million, as compared to $391.6 million for the nine months ended September 30, 2024, also mainly driven by recent acquisitions, as well as strong demand for nuclear safety and crowd control products.
For the quarter ended September 30, 2025, Cadre generated gross profit of $66.6 million, as compared to $40.0 million for the quarter ended September 30, 2024. For the nine months ended September 30, 2025, Cadre generated gross profit of $187.0 million, as compared to $156.3 million for the prior year period.
Gross profit margin was 42.7% for the quarter ended September 30, 2025, as compared to 36.6% for the quarter ended September 30, 2024, mainly driven by increased volume, favorable pricing net of material inflation, and a decrease in inventory step-up amortization. Gross profit margin was 42.2% for the nine months ended September 30, 2025, as compared to 39.9% for the prior year period.
Net income was $10.9 million for the quarter ended September 30, 2025, as compared to net income of $3.7 million for the quarter ended September 30, 2024. The increase was primarily as a result of increased gross profit, partially offset by increases in selling, general and administrative expenses, as well as other costs.
Net income was $32.4 million for the nine months ended September 30, 2025, as compared to net income of $23.2 million for the prior year period, primarily as a result of increased gross profit and gains from foreign exchange rates partially offset by increases in compensation expense, interest expense and provision for taxes.
Cadre generated $29.8 million of Adjusted EBITDA for the quarter ended September 30, 2025, as compared to $13.5 million for the quarter ended September 30, 2024. Adjusted EBITDA margin was 19.1% for the quarter ended September 30, 2025, as compared to 12.4% for the prior year period.
Cadre generated $77.3 million of Adjusted EBITDA for the nine months ended September 30, 2025, as compared to $66.3 million for the prior period. Adjusted EBITDA margin was 17.4% for the nine months ended September 30, 2025, as compared to 16.9% for the prior year period.
Product segment gross margin was 43.9% and 43.3% for the third quarter and first nine months of 2025, respectively, compared to 37.4% and 40.7% for the prior year periods.
Distribution segment gross margin was 21.3% and 22.0% for the third quarter and first nine months of 2025, respectively, compared to 21.9% and 22.9% for the prior year periods.
Liquidity, Cash Flows and Capital Allocation
Acquisition of TYR Tactical
On October 28, 2025, Cadre announced it has entered into a definitive agreement to acquire TYR Tactical, LLC, a leading global manufacturer of tactical gear and equipment for military, law enforcement, and government agencies worldwide. TYR Tactical produced approximately $92.6 million of revenue in the year ended December 31, 2024, and is expected to be immediately accretive to earnings and Adjusted EBITDA margins. The total consideration is $175 million and is anticipated to close in the first half of 2026.
Med-Eng Wins $50 Million Contract with the Department of Defense
On September 26, 2025, Cadre subsidiary Med-Eng, LLC was awarded a $50 million Indefinite Delivery / Indefinite Quantity (ID/IQ) contract by the United States Department of Defense (DoD), known as the Blast Exposure Monitoring System (BEMO). At the time of award, Med-Eng received the first purchase order for $10 million to be shipped in 2026.
On October 21, 2025, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on November 14, 2025 to shareholders of record as of the close of business on the record date of October 31, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors.
For the full year 2025, Cadre expects to generate net sales in the range of $624 million to $630 million and Adjusted EBITDA in the range of $112 million and $116 million. We expect capital expenditures to be in the range of $7 million to $8 million. Cadre has not provided net income guidance due to the inherent difficulty of forecasting certain types of expenses and gains, which affect net income but not Adjusted EBITDA. Therefore, we do not provide a reconciliation of Adjusted EBITDA guidance to net income guidance.
Management will host a conference call on Wednesday, November 5, 2025, at 10:00 a.m. EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (800)-715-9871 and the dial-in number for international callers is 646-307-1963. The access code for all callers is 9511718. A live webcast will also be available on the Company's website at https://www.cadre-holdings.com/.
A replay of the call will be available through November 19, 2025. To access the replay, please dial 800-770-2030 in the U.S. or +1-609-800-9909 if outside the U.S., and then enter the access code 9511718.
Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety products. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland and Med-Eng , amongst others.
Use of Non-GAAP Measures
The Company reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). The press release contains the non-GAAP measures: (i) earnings before interest, taxes, other income or expense, depreciation and amortization ("EBITDA"), (ii) Adjusted EBITDA, (iii) Adjusted EBITDA margin and (iv) last twelve months Adjusted EBITDA. The Company believes the presentation of these non-GAAP measures provides useful information for the understanding of its ongoing operations and enables investors to focus on period- over-period operating performance, and thereby enhances the user's overall understanding of the Company's current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. We do not provide a reconciliation of the non-GAAP guidance measure Adjusted EBITDA for the fiscal year 2025 to net income for the fiscal year 2025, the most comparable GAAP financial measure, due to the inherent difficulty of forecasting certain types of expenses and gains, without unreasonable effort, which affect net income but not Adjusted EBITDA. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company's reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.
Forward-Looking Statements
Please note that in this press release we may use words such as "appears," "anticipates," "believes," "plans," "expects," "intends," "future," and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based
on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this press release, include, but are not limited to, those risks and uncertainties more fully described from time to time in the Company's public reports filed with the Securities and Exchange Commission, including under the section titled "Risk Factors" in the Company's Annual Report on Form 10-K, and/or Quarterly Reports on Form 10-Q, as well as in the Company's Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release and speak only as of the date hereof. We assume no obligation to update any forward- looking statements to reflect events or circumstances after the date of this press release.
Cadre Holdings, Inc.
Leon Berman / Matt Berkowitz
212-477-8438 / 212-227-7098
CADRE HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
| September 30, 2025 | December 31, 2024 | |||||
| Assets | ||||||
| Current assets | ||||||
| Cash and cash equivalents | $ | 150,875 | $ | 124,933 | ||
| Accounts receivable, net of allowance for doubtful accounts of $826 and $876, respectively | 99,426 | 93,523 | ||||
| Inventories | 112,201 | 82,351 | ||||
| Prepaid expenses | 12,474 | 19,027 | ||||
| Other current assets | 11,240 | 7,737 | ||||
| Total current assets | 386,216 | 327,571 | ||||
| Property and equipment, net of accumulated depreciation and amortization of $60,893 and $54,384, respectively | 77,590 | 45,243 | ||||
| Operating lease assets | 21,719 | 15,454 | ||||
| Deferred tax assets, net | 4,857 | 4,552 | ||||
| Intangible assets, net | 117,909 | 107,544 | ||||
| Goodwill | 179,169 | 148,157 | ||||
| Other assets | 4,595 | 4,192 | ||||
| Total assets | $ | 792,055 | $ | 652,713 | ||
| Liabilities, Mezzanine Equity and Shareholders' Equity | ||||||
| Current liabilities | ||||||
| Accounts payable | $ | 26,997 | $ | 29,644 | ||
| Accrued liabilities | 61,363 | 46,413 | ||||
| Income tax payable | 1,418 | 6,693 | ||||
| Current portion of long-term debt | 16,266 | 11,375 | ||||
| Total current liabilities | 106,044 | 94,125 | ||||
| Long-term debt | 294,971 | 211,830 | ||||
| Long-term operating lease liabilities | 16,033 | 10,733 | ||||
| Deferred tax liabilities | 24,110 | 18,758 | ||||
| Other liabilities | 10,523 | 5,752 | ||||
| Total liabilities | 451,681 | 341,198 | ||||
| Mezzanine equity | ||||||
| Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2025 and December 31, 2024) | - | - | ||||
| Shareholders' equity | ||||||
| Common stock ($0.0001 par value, 190,000,000 shares authorized, 40,681,668 and 40,607,988 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively) | 4 | 4 | ||||
| Additional paid-in capital | 312,910 | 306,821 | ||||
| Accumulated other comprehensive income (loss) | 565 | (1,389) | ||||
| Accumulated earnings | 26,895 | 6,079 | ||||
| Total shareholders' equity | 340,374 | 311,515 | ||||
| Total liabilities, mezzanine equity and shareholders' equity | $ | 792,055 | $ | 652,713 |
CADRE HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share amounts)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||
| Net sales | $ | 155,869 | $ | 109,408 | $ | 443,084 | $ | 391,577 | ||||
| Cost of goods sold | 89,244 | 69,392 | 256,079 | 235,283 | ||||||||
| Gross profit | 66,625 | 40,016 | 187,005 | 156,294 | ||||||||
| Operating expenses | ||||||||||||
| Selling, general and administrative | 45,627 | 33,981 | 132,509 | 113,277 | ||||||||
| Restructuring and transaction costs | 2,216 | 515 | 6,240 | 3,621 | ||||||||
| Related party expense | 108 | 94 | 1,345 | 2,038 | ||||||||
| Total operating expenses | 47,951 | 34,590 | 140,094 | 118,936 | ||||||||
| Operating income | 18,674 | 5,426 | 46,911 | 37,358 | ||||||||
| Other expense | ||||||||||||
| Interest expense, net | (3,028) | (1,991) | (8,849) | (5,631) | ||||||||
| Other (expense) income, net | (802) | 1,555 | 6,599 | (225) | ||||||||
| Total other expense, net | (3,830) | (436) | (2,250) | (5,856) | ||||||||
| Income before provision for income taxes | 14,844 | 4,990 | 44,661 | 31,502 | ||||||||
| Provision for income taxes | (3,903) | (1,335) | (12,261) | (8,352) | ||||||||
| Net income | $ | 10,941 | $ | 3,655 | $ | 32,400 | $ | 23,150 | ||||
| Net income per share: | ||||||||||||
| Basic | $ | 0.27 | $ | 0.09 | $ | 0.80 | $ | 0.58 | ||||
| Diluted | $ | 0.27 | $ | 0.09 | $ | 0.79 | $ | 0.58 | ||||
| Weighted average shares outstanding: | ||||||||||||
| Basic | 40,666,861 | 40,607,988 | 40,649,339 | 39,723,702 | ||||||||
| Diluted | 40,977,677 | 40,949,461 | 40,964,737 | 40,118,729 |
CADRE HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine Months Ended September 30, | ||||||
| 2025 | 2024 | |||||
| Cash Flows From Operating Activities: | ||||||
| Net income | $ | 32,400 | $ | 23,150 | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
| Depreciation and amortization | 13,908 | 12,325 | ||||
| Amortization of original issue discount and debt issue costs | 1,075 | 787 | ||||
| Amortization of inventory step-up | 826 | 3,851 | ||||
| Deferred income taxes | (4,163) | (11,627) | ||||
| Stock-based compensation | 6,840 | 6,255 | ||||
| Remeasurement of contingent consideration | 1,489 | 685 | ||||
| (Recoveries from) provision for losses on accounts receivable | (190) | 757 | ||||
| Unrealized foreign exchange transaction gain | (2,275) | (788) | ||||
| Other loss | 268 | 355 | ||||
| Changes in operating assets and liabilities, net of impact of acquisitions: | ||||||
| Accounts receivable | 19,360 | 162 | ||||
| Inventories | (14,748) | (2,589) | ||||
| Prepaid expenses and other assets | 4,607 | (4,161) | ||||
| Accounts payable and other liabilities | (16,942) | (21,096) | ||||
| Net cash provided by operating activities | 42,455 | 8,066 | ||||
| Cash Flows From Investing Activities: | ||||||
| Purchase of property and equipment | (3,582) | (4,381) | ||||
| Proceeds from disposition of property and equipment | 6 | 74 | ||||
| Business acquisitions, net of cash acquired | (89,590) | (141,813) | ||||
| Net cash used in investing activities | (93,166) | (146,120) | ||||
| Cash Flows From Financing Activities: | ||||||
| Proceeds from revolving credit facilities | - | 5,500 | ||||
| Principal payments on revolving credit facilities | - | (5,500) | ||||
| Proceeds from term loans | 97,500 | 80,000 | ||||
| Principal payments on term loans | (9,723) | (9,562) | ||||
| Principal payments on insurance premium financing | - | (2,187) | ||||
| Payments for debt issuance costs | - | (844) | ||||
| Taxes paid in connection with employee stock transactions | (1,185) | (5,311) | ||||
| Proceeds from secondary offering, net of underwriter discounts | - | 91,776 | ||||
| Deferred offering costs | - | (683) | ||||
| Dividends distributed | (11,584) | (10,395) | ||||
| Other | 344 | 37 | ||||
| Net cash provided by financing activities | 75,352 | 142,831 | ||||
| Effect of foreign exchange rates on cash and cash equivalents | 1,301 | 521 | ||||
| Change in cash and cash equivalents | 25,942 | 5,298 | ||||
| Cash and cash equivalents, beginning of period | 124,933 | 87,691 | ||||
| Cash and cash equivalents, end of period | $ | 150,875 | $ | 92,989 | ||
| Supplemental Disclosure of Cash Flows Information: | ||||||
| Cash paid for income taxes, net | $ | 22,545 | $ | 22,761 | ||
| Cash paid for interest | $ | 13,075 | $ | 10,523 | ||
| Supplemental Disclosure of Non-Cash Investing and Financing Activities: | ||||||
| Accruals and accounts payable for capital expenditures | $ | 16 | $ | 112 |
CADRE HOLDINGS, INC.
| Three Months Ended September 30, 2025 | ||||||||||||
| Reconciling | ||||||||||||
| Product | Distribution | Items (1) | Total | |||||||||
| Net sales | $ | 138,789 | $ | 26,483 | $ | (9,403) | $ | 155,869 | ||||
| Cost of goods sold | 77,862 | 20,843 | (9,461) | 89,244 | ||||||||
| Gross profit | $ | 60,927 | $ | 5,640 | $ | 58 | $ | 66,625 |
| Three Months Ended September 30, 2024 | ||||||||||||
| Reconciling | ||||||||||||
| Product | Distribution | Items (1) | Total | |||||||||
| Net sales | $ | 96,493 | $ | 17,836 | $ | (4,921) | $ | 109,408 | ||||
| Cost of goods sold | 60,386 | 13,936 | (4,930) | 69,392 | ||||||||
| Gross profit | $ | 36,107 | $ | 3,900 | $ | 9 | $ | 40,016 |
| Nine Months Ended September 30, 2025 | ||||||||||||
| Reconciling | ||||||||||||
| Product | Distribution | Items (1) | Total | |||||||||
| Net sales | $ | 391,659 | $ | 79,853 | $ | (28,428) | $ | 443,084 | ||||
| Cost of goods sold | 222,189 | 62,293 | (28,403) | 256,079 | ||||||||
| Gross profit | $ | 169,470 | $ | 17,560 | $ | (25) | $ | 187,005 |
| Nine Months Ended September 30, 2024 | ||||||||||||
| Reconciling | ||||||||||||
| Product | Distribution | Items (1) | Total | |||||||||
| Net sales | $ | 343,711 | $ | 71,615 | $ | (23,749) | $ | 391,577 | ||||
| Cost of goods sold | 203,771 | $ | 55,216 | $ | (23,704) | 235,283 | ||||||
| Gross profit | $ | 139,940 | $ | 16,399 | $ | (45) | $ | 156,294 |
CADRE HOLDINGS, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
| Year ended | Three Months Ended | Nine Months Ended | Last Twelve | |||||||||||||||
| December 31, | September 30, | September 30, | Months | |||||||||||||||
| 2024 | 2025 | 2024 | 2025 | 2024 | September 30, 2025 | |||||||||||||
| Net income | $ | 36,133 | $ | 10,941 | $ | 3,655 | $ | 32,400 | $ | 23,150 | $ | 45,383 | ||||||
| Add back: | ||||||||||||||||||
| Depreciation and amortization | 16,420 | 5,376 | 3,763 | 13,908 | 12,325 | 18,003 | ||||||||||||
| Interest expense, net | 7,822 | 3,028 | 1,991 | 8,849 | 5,631 | 11,040 | ||||||||||||
| Provision for income taxes | 18,085 | 3,903 | 1,335 | 12,261 | 8,352 | 21,994 | ||||||||||||
| EBITDA | $ | 78,460 | $ | 23,248 | $ | 10,744 | $ | 67,418 | $ | 49,458 | $ | 96,420 | ||||||
| Add back: | ||||||||||||||||||
| Restructuring and transaction costs (1) | 7,757 | 2,216 | 515 | 7,240 | 5,371 | 9,626 | ||||||||||||
| Other expense (income), net (2) | 4,721 | 802 | (1,555) | (6,599) | 225 | (2,103) | ||||||||||||
| Stock-based compensation expense (3) | 8,369 | 2,447 | 2,104 | 6,840 | 6,255 | 8,954 | ||||||||||||
| Stock-based compensation payroll tax expense (4) | 441 | - | - | 92 | 441 | 92 | ||||||||||||
| LTIP bonus (5) | 49 | - | - | - | 49 | - | ||||||||||||
| Amortization of inventory step-up (6) | 3,858 | 470 | 1,541 | 826 | 3,851 | 833 | ||||||||||||
| Contingent consideration expense (7) | 1,185 | 632 | 176 | 1,489 | 685 | 1,989 | ||||||||||||
| Adjusted EBITDA | $ | 104,840 | $ | 29,815 | $ | 13,525 | $ | 77,306 | $ | 66,335 | $ | 115,811 | ||||||
| Adjusted EBITDA margin (8) | 18.5 | % | 19.1 | % | 12.4 | % | 17.4 | % | 16.9 | % |